1Pollice PF, Rosier RN, Looney RJ. Oral pentoxifylline inhibits release of tumor necrosis factor - alpha from human peripheral bloodmonocytes : a potential treatment for aseptic loosening of total joint components. J Bone Joint Surg (Am), 2001, 83 (7): 105
2Kelly J, Rudd A, Lewis RR. Plasma D- dimers in the diagnosis of venous thromboembolism. Arch Intern Med, 2002, 162 (7): 747
3Charlwood AP, Thompson NW, Thompson NS. Recurrent hip arthroplasty dislocation . Acta Orthop Scand, 2002, 73 (5): 502
4Michael H. Hvo, Scott M. Cook. What's new in hip arthroplasry. JBoneJointSurg (Am), 2001, 83 (10): 1598
5Sessa G, Costarella L, Mollica R. Heterotopic ossification after total hip replacement and the HLA system in the Sicilian population. J Orthop Traumatol, 2002, 2 (3): 125
6Popken F, Knig DP, Tantow M. Possibility of sonographic early diagnosis of heterotopic ossifications after total hip- replacement. Unfallchirurg, 2003, 106 (1): 28
7Wilkinson JM, Stockley I, Hamer AJ. Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res, 2003, 21 (3): 529
8Fijn R, Koorevaar RT, Brouwers JR. Prevention of heterotopic ossification after total hip replacement with NSAIDs. Pharm World Sci,2003, 25 (4): 138
9Parvizi J, Morrey BF. Bipolar hip arthroplasty as a salvage treatment for instability of the hip. J Bone Joint Surg (Am), 2000, 82 (8):1132
10Cheng JW. Fondaparinux: a new antithrombotic agent. Clin Ther,2002, 24 (11): 1757
